GENETIC ASPECTS OF OSTEOPOROSIS
Borisova A-M, Antanasova I*
*Corresponding Author: Professor Iliana Atanasova, Clinical Centre of Endocrinology, Medical University, Sofia-1303, Damian Gruev str. 6, Bulgaria; Tel: +359-2-987-72-01, Fax +359-2-987-41-45; E-mail: atanasova@uheg.medicalnet-bg.org
page: 11

REFERENCES

1. Fleisch H. Bone and mineral metabolism. In: Fleisch H, ed. Bisphosphonates in Bone disease. London: The Parthenon Publishing Group, Butler & Tanner Ltd., 1995; 11-28.

      2. Brown M, Duncan E. Genetic studies of osteoporosis. In: Expert Reviews in Molecular Medicine. Cam­bridge: Cambridge University Press, 1999; 1-17.

      3. Russell G. Bone metabolism and its regulation. In: Easterll R, Baumann M, Hoyle NR, Wieczorek L, eds. Bone Markers. London: Martin Dunitz, 2001; 1-26.

      4. Christgau S, Rosenquist C, Alexandersen P, Bjarnason NH, Ravn P, Fledelius C, Herling C, Qvist P, Christiansen C. Clinical evaluation of the serum Cross­Laps One step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. Clin Chem 1998; 44: 2290-2300.

      5. Weaver CM. Adolescence – The period of dramatic bone growth. Endocrine 2002; 17(1): 43-48.

      6. Kanis JA, Devogelaer J-P, Gennari C. Bone Density Measurement in the Assessment and Treatment of Osteoporosis: Practical Guidelines. London: Blackwell Healthcare Ltd., 1997.

      7. National Institutes of Health, Bethesda, MD, USA. Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement 2000; 17: 1-45.

      8. Nguyen TV, Blangero J, Eisman JA. Genetic epidemiological approaches to the search for osteoporosis genes. J Bone Miner Res 2000; 15: 392-401.

      9. Ongphiphadhanakul B. Genetic polymorphisms of estrogen receptor-a: possible implications for targeted osteoporosis therapy. Am J Pharmacogenomics 2003; 3: 5-9.

      10. Uitterlinden AG. Relation of alleles of the collagen type 1 a 1 gene to bone density and the risk of osteo­porotic fractures in both men and women. N Engl J Med 1998; 338: 1016-1021.

      11. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type 1 a 1 gene. Nat Genet 1996; 14: 203-205.

      12. Langdahl BI, Ralston SH, Grant SF, Eriksen EF. An Sp1 binding site polymorphism in the COL1A1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 1998; 13: 1384-1389.

      13. Keen RW, Woodford-Richens K, Grant SF, Ralston SH, Lanchbury JS, Spector TD. Association of polymorphism at the type 1 collagen (COL1A1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 1999; 42: 285-290.

      14. Duncan E, Brown MA, Sinsheimer J, Bell J, Carr AJ, Wordsworth BP, Wass JA. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res 1999; 14: 1993-1999.

      15. Brown MA, Houghton MA, Grant SF, Gunnell AS, Henderson NV, Eisman JA. The genetic control of bone density and turnover: the role of the COL1A1, estrogen receptor and VDR genes. J Bone Miner Res 2001; 16: 758- 763.

      16. Brown MA, Eisman JA. The genetics of osteoporosis. Future diagnostic possibilities. Clin Lab Med 2000; 20: 527-547.

      17. Mann V, Hobson E, Li B, Stewart TL, Grant SF, robins SP, Aspden RM, Ralston SH. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture affecting bone density and quality. J Clin Invest 2001; 107: 899-907.

      18. Cole D, Vieth R, Tzang HM, Wong BJ, Hendy GN, Rubin LA. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 2001; 72: 168-174.

      19. Mann V, Ralston SH. Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 2003; 32: 711-717.

      20. Morrison NA, Jeoman R, Kelly PY, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-6669.

      21. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367(6460): 264-267. [Erratum: Nature 1997; 387 (6625): 106.]

      22. Wishart JM, Horowitz M, Need AG, Scopacasa F, Morris HA, Clifton PM, Nordin BE. Relation between calcium intake, calcitriol, polymorphism of the vitamin D receptor gene, and calcium absorption in premenopausal women. Am J Clin Nutr 1997; 65: 798-802.

      23. Dawson-Huges B, Harris SS, Finneran S. Calcium absorption on high and low calcium intakes in relation to vitamin D receptor genotype. J Clin Endocrinol Metab 1995; 80: 3657-3661.

      24. Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G. Vitamin D receptor gene polymor­phism, bone mass, body size, and vitamin D receptor density. Calcif Tissue Int 1995; 57: 161-162.

      25. Gross C. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmeno­pausal Mexican-American women. J Bone Miner Res 1996; 11: 1850-1855.

      26. Gross C, Krishnan AV, Malloy PJ, Eccleshall TR, Zhao XY, Feldman D. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Res 1998; 13(11): 1691-1699.

      27. Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour J. Vitamin D receptor gene start codon polymor­­­­phisms (FokI) and bone mineral density: interaction with age, dietary calcium, and 3’-end region polymorphisms. J Bone Miner Res 1998; 13: 925-930.

      28. Eccleshall TR. Lack of correlation between start codon polymorphisms of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 1998; 13: 31-35.

      29. Lucotte G, Mercier G, Burckel A. The vitamin D receptor FokI start codon polymorphism and bone mineral density in osteoporotic postmenopausal French women. Clin Genet 1999; 56: 221-224.

      30. Sowers M, Willing M, Burns T, Deschenes S, Hollis B, Crutchfield M, Jannausch M. Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 1999; 14: 1411-1419.

      31. Palomba S, Numis FG, Mossetti G, Rendina D, Vuotto P, Russo T, Zullo F, Nappi C, Nunziata V. Raloxi­fene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes. Hum Repro 2003; 18: 192-198.

      32. Farach-Carson MC, Nemere I. Membrane receptors for vitamin D steroid hormones: potential new drug targets. Curr Drug Targets 2003; 4: 67-76.

      33. Kubodera N, Tsuji N, Uchiyama Y, Endo K. A new active vitamin D analogue, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients. J Cell Biochem 2003; 88: 286-289.

      34. McCauley LK. Transgenic mouse models of metabolic bone disease. Curr Opin Rheumatol 2001; 13: 316-325.

      35. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994; 331: 1056-1061.

      36. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 1996; 11: 306-311.

      37. Willing M, Sowers M, Aron D, Clark MK, Burns T, Burden C, Cruchfield M, D’Agostino D, Jannausch M. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998; 13: 695-705.

      38. Gennari L, Becherini L, Masi L, Mansani R, Gonnelli S., Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML. Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 1998; 83: 939-944.

      39. Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK. Non association of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmeno­pausal women. J Clin Endocrinol Metab 1997; 82: 991-995.

      40. Ushiroyama T, Heishi M, Higashio S, Ikeda A, Ueki M. The association between postmenopausal vertebral bone mineral density and estrogen receptor gene alleles in ethnic Japanese living in western Japan. Res Com­mun Mol Pathol Pharmacol 2001; 109: 15-24.

      41. van der Sluis IM, de Muinck Keizer-Schrama SM, Krenning EP, Pols HA, Uitterlinden AG. Vitamin D receptor gene polymorphism predicts height and bone size, rather than bone density in children and young adults. Calcif Tissue Int 2003; 87: 208-215.

      42. Brown MA, Haughton MA, Grant SF, Gunnell AS, Henderson NK, Eisman JA. Genetic control of bone density and turnover: role of the collagen 1 a1, estrogen receptor, and vitamin D receptor genes. J Bone Miner Res 2001; 16: 758-764.

      43. Murray RE, McGuigan F, Grant SF, Reid DM, Ralston SH. Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 1997; 21: 89-92.

      44. Tsukamoto K, Ohta N, Shirai Y, Emi M. Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenopausal Japanese women. J Hum Genet 1998; 44: 148-151.

      45. Yamada Y. Association of polymorphisms of the transforming growth factor-b1 gene with genetic susceptibility to osteoporosis. Pharmacogenetics 2001; 11: 765-771.

      46. Langdahl B I, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF. A sequence variation: 713-8delC in the transforming growth factor b I gene has higher prevalence in osteoporotic women than in normal women and in association with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 1997; 20: 289-294.

      47. Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-b gene. Bone 1998; 23: 87-93.

      48. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF. Targeted disruption of the biglycan gene leads to an osteoporosis-like pheno­ptype in mice. Nat Genet 1998; 20: 78-82.

      49. Erlebacher A, Filvaroff EH, Ye JQ, Derynck R. Osteoblastic responses to TGF-b during bone remodeling. Mol Biol Cell 1998; 9: 1903-1918.

      50. Pluijm SM, Dik MG, Jonker C, Deeg DJ, van Kamp GJ, Lips P. Effects of gender and age on the association of apolipoprotein E e 4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int 2002; 13: 701-709.

      51. Masi L, Becherini L, Colli E, Gennari L, Mansani R, Falchetti A, Becorpi A.M, Cepollaro C, Gonnelli S, Tanini A, Brandi ML. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Commun 1998; 248: 190-195.

      52. Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD. Allelic variation at the inetrleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 1998; 23: 367-371.

      53. Dohi Y, Iki M, Ohgushi H, Gojo S, Tabata S, Kajita E, Nishino H, Yonemasu K. A novel polymorphism in the promoter region for the human osteocalcin gene: the possibility of a correlation with bone mineral density in postmenopausal Japanese women. J Bone Miner Res 1998; 13: 1633-1639.

      54. Hosoi T, Miyao M, Inoue S, Hoshino S, Shiraki M, Orimo H, Ouchi Y. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women. Calcif Tissue Int 1999; 64: 205-208.

      55. Tsuji S, Munkhbat B, Hagihara M, Tsuritani I, Abe H, Tsuji K. HLA A 24-B*07-DRB1*01 haplotype implicated with genetic disposition of peak bone mass in healthy young Japanese women. Hum Immunol 1998; 59: 243-249.

      56. Chen HY, Chen WC, Wu MC, Tsai FJ, Lin CC. Interleukin-1 b and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Maturitas 2003; 44: 49-54.

      57. Devoto M, Shimoya K, Caminis J, Ott J, Tenen­house A, Whyte MP, Sereda L, Hall S, Considine E, Williams CJ, Tromp G, Kuivaniemi H, Ala-Kokko L, Prockop DJ, Spotila LD. First stage autosomal genome screen in extended pedigree suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p, and 4q. Eur J Hum Genet 1998; 6: 151-157.

      58. van Hul E, Gram J, Bollerslev J, van Wesenbeeck L, Mathysen D, Andersen PE, Vanhoenacker F, van Hul W: Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. J Bone Miner Res 2002; 17: 1111-1117.

      59. Koller DL, Rodriguez LA, Christian JC, Slemenda CW, Econs MJ, Hui SL, Morin P, Conneally PM, Joslyn G, Curran ME, Peacock M, Johnston CC, Foroud T. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13. J Bone Miner Res 1998; 13: 1903-1908.

      60. Heaney C, Shalev H, Elbedour K, Carmi R, Staack JB, Sheffield VC, Beier DR. Human autosomal recessive osteopetrosis maps to 11q13, a position pre­dicted by comparative mapping of the murine osteo­sclerosis (oc) mutation. Hum Mol Genet 1998; 7: 1407-1410.

      61. Gong Y, Vikkula M, Boon L, Liu J, Beighton., Ramesar R, Peltonen L, Somer H, Hirose T, Dallapiccola B, De Paepe A, Swoboda W, Zabel B, Superti-Furga A, Steinmann B, Brunner HG, Jans A, Boles RG, Adkins W, van den Boogaard MJ, Olsen BR, Warman ML. Osteoporosis-pseudoglioma syndrome, a disorder affecting skeletal strength and vision is assigned to chromosomal region 11q12-13. Am J Hum Genet 1996; 59: 146-151.

      62. Todd JA. From genome to aetiology in a multi­factorial disease, type I diabetes. Bioassays 1999; 21: 164-174.




Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006